AdvisorShares Psychedelics ETF (PSIL)
NYSEARCA: PSIL · Real-Time Price · USD
14.78
-0.30 (-1.96%)
Jul 15, 2025, 4:00 PM - Market closed
PSIL Holdings Information
PSIL is an equity ETF with a total of 26 individual holdings. The top holdings are Atai Life Sciences stock at 9.22%, Mind Medicine (MindMed) at 7.98%, NRx Pharmaceuticals at 7.65%, Cybin at 7.34%, and Alkermes at 7.13%.
Total Holdings
26
Top 10 Percentage
70.00%
Asset Class
Equity
ETF Category
Miscellaneous Sector
Assets
11.22M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | ATAI | Atai Life Sciences N.V. | 9.22% |
| 2 | MNMD | Mind Medicine (MindMed) Inc. | 7.98% |
| 3 | NRXP | NRx Pharmaceuticals, Inc. | 7.65% |
| 4 | NEO: CYBN | Cybin Inc. | 7.34% |
| 5 | ALKS | Alkermes plc | 7.13% |
| 6 | SAGE | Sage Therapeutics, Inc. | 7.00% |
| 7 | CSE: QNTM | Quantum BioPharma Ltd. | 6.24% |
| 8 | CMPS | COMPASS Pathways plc | 6.06% |
| 9 | GHRS | GH Research PLC | 5.77% |
| 10 | NBIX | Neurocrine Biosciences, Inc. | 5.62% |
| 11 | STIM | Neuronetics, Inc. | 5.08% |
| 12 | NEUP | Neuphoria Therapeutics Inc. | 4.71% |
| 13 | VTGN | Vistagen Therapeutics, Inc. | 4.36% |
| 14 | CSE: DRUG | Bright Minds Biosciences Inc. | 3.47% |
| 15 | TTTXX | BlackRock Treasury Trust Fund | 3.16% |
| 16 | RLMD | Relmada Therapeutics, Inc. | 2.18% |
| 17 | CMND | Clearmind Medicine Inc. | 1.77% |
| 18 | KTTA | Pasithea Therapeutics Corp. | 1.33% |
| 19 | ENVB | Enveric Biosciences, Inc. | 1.23% |
| 20 | SILO | Silo Pharma, Inc. | 1.11% |
| 21 | TSX: NUMI | Numinus Wellness Inc. | 0.71% |
| 22 | IXHL | Incannex Healthcare Inc. | 0.68% |
| 23 | PBM | Psyence Biomedical Ltd. | 0.21% |
| 24 | n/a | Cash | 0.00% |
| 25 | CSE: QNTM | Quantum BioPharma Ltd. | 0.00% |
As of Jul 11, 2025